| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| VISINE CLASSIC 0,5 mg/ml | TETRYZOLINUM | PICATURI OFT., SOL. | S01GA02 | W64914001 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| VISINE CLASSIC 0,5 mg/ml | TETRYZOLINUM | PICATURI OFT., SOL. | S01GA02 | W64914002 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| VISINE NOVO 0,5 mg/ml | TETRYZOLINUM | PIC. OFT., SOL. | S01GA02 | W67737001 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012001 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012002 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012003 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012004 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012005 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012007 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 270 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12012008 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013001 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013002 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013003 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013004 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013005 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013006 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISIPAQUE 320 mg I/ml | IODIXANOLUM | SOL. INJ. | V08AB09 | W12013007 | GE HEALTHCARE AS - NORVEGIA | ||||||
| VISTABEL, 4 unitati Allergan/0,1 ml | TOXINA BOTULINICA DE TIP A | PULB. PT. SOL. INJ. | M03AX01 | W69201001 | ABBVIE LIMITED - IRLANDA | ||||||
| VISTABEL, 4 unitati Allergan/0,1 ml | TOXINA BOTULINICA DE TIP A | PULB. PT. SOL. INJ. | M03AX01 | W69201002 | ABBVIE LIMITED - IRLANDA | ||||||
| VISTABEL, 4 unitati Allergan/0,1 ml | TOXINA BOTULINICA DE TIP A | PULB. PT. SOL. INJ. | M03AX01 | W69201003 | ABBVIE LIMITED - IRLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman